1.
Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).
2.
3.
4.
Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study
Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse aft...
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological...
Practical management of Chronic Myeloid Leukemia in Belgium
Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study
Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.
Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique ; Overview of the general management of acute leukemia for adults
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.
5.
6.
7.